Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06139458 · ClinicalTrials.gov registry record · NA
Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2
A NA study of Gynecologic Cancer and Chemotherapy-induced Peripheral Neuropathy, sponsored by Duke University.
- Recruiting
- Registry status
- NA
- Development phase
- 190
- Enrollment target
- 2
- Study locations
NCT06139458 is a NA study of Gynecologic Cancer and Chemotherapy-induced Peripheral Neuropathy that is actively recruiting participants, run by Duke University. The registered enrollment target is 190 participants, below the 761-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (75% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT06139458, a NA study of Gynecologic Cancer and Chemotherapy-induced Peripheral Neuropathy, is actively recruiting participants, sponsored by Duke University.
- RECRUITING
- Registry status
- NA
- Development phase
- 190 participants
- Enrollment target
- 2
- Study locations
Study Summary
The investigators aim to determine the effect of cryotherapy wraps plus compression therapy (henceforth referred to as cryocompression) versus cryotherapy wraps alone on the incidence and degree of chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer using a noninferiority design. The investigators also aim to determine the effect of cryocompression versus cryotherapy on patient tolerability and patient and staff satisfaction.
Conditions Studied
Interventions
- BEHAVIORAL Cryotherapy
- BEHAVIORAL Compression
Study Locations (2)
North Carolina
- Duke University Medical Center - Durham
Virginia
- Carilion Clinic - Roanoke
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 190 participants |
| Start Date | 2024-01-18 |
| Est. Completion | 2027-05-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06139458
The ClinicalTrials.gov registry entry for NCT06139458 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 190 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 761-participant average among 55 other Gynecologic Cancer trials with a reported enrollment target (75% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Gynecologic Cancer appearing as the primary indexed condition, and to 2 interventions - of which Cryotherapy is the first listed.
NCT06139458 reports 2 study locations spanning 2 distinct geographic areas - top geographies include North Carolina, Virginia.
Frequently Asked Questions
What is clinical trial NCT06139458 about?
NCT06139458 is a clinical study titled "Cryocompression to Reduce Chemotherapy-induced Peripheral Neuropathy in Gynecologic Cancer - COHORT 2". The investigators aim to determine the effect of cryotherapy wraps plus compression therapy (henceforth referred to as cryocompression) versus cryotherapy wraps alone on the incidence and degree of chemotherapy-induced peripheral neuropathy in patients with gynecologic cancer using a noninferiority ...
What is the current status of trial NCT06139458?
This trial is currently recruiting. It is a NA study. The enrollment target is 190 participants. The study started on 2024-01-18. Estimated completion is 2027-05-31.
What conditions does trial NCT06139458 study?
This clinical trial studies the following conditions: Gynecologic Cancer, Chemotherapy-induced Peripheral Neuropathy.
What interventions are being tested in trial NCT06139458?
The interventions under investigation include: Cryotherapy (BEHAVIORAL), Compression (BEHAVIORAL).
Who is sponsoring clinical trial NCT06139458?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06139458 being conducted?
This trial has 2 study locations across North Carolina, Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Gynecologic Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Prospective Evaluation of Pencil Beam Scanning Proton Therapy for Previously Irradiated Tumors
RECRUITING · NA
-
Chatbot to Maximize Hereditary Cancer Genetic Risk Assessment
RECRUITING · NA
-
BOLSTER: Learning New Skills to Thrive
RECRUITING · NA
-
A Study Evaluating the Integrative Medicine at Home (IM@HOME) Program in People With Cancer
RECRUITING · NA
-
Activity Coaching During Pelvic Radiation Therapy
RECRUITING · NA
-
Transcranial Magnetic Stimulation for Chemotherapy-Induced Peripheral Neuropathy in Breast and Gynecologic Cancer Survivors
RECRUITING · NA
Explore more on PlainTrial
Gynecologic Cancer
All registered trials for this condition
Chemotherapy-induced Peripheral Neuropathy
All registered trials for this condition
North Carolina
All trials with a study site in North Carolina
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.